Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Associated investigators

Associated investigators Inge Jonassen, Jan Erik Askildsen, John Cairns, Ole-Frithjof Norheim, Line Bjørge, Daniela Elena Costea, Camilla Krakstad and Elisabeth Wik.

Updated: 13.02.2019 (First published: 23.04.2014)
Portrait photo.

Bioinformatics

Professor Inge Jonassen and part of his team from the CBU (Computational Bioinformatics Unit, Department of Informatics, UiB) are working on the development and application of bioinformatics methods for analysing data descending from high-throughput measurement technologies applied to cancer samples.

Portrait photo.

Health Economics

Health economics at CCBIO is concerned with two major research problems: what is the cost-effectiveness of biomarkers, and how does the interplay between the diagnostic market and the pharmaceutical market affect incentives to invest in R&D for cancer biomarkers, termed the industrial...

Portrait photo.

Global Health Priorities - Ole-Frithjof Norheim

Global Health Priorities is an interdisciplinary research group situated at the Department of Global Health and Primary Care at the University of Bergen. The group consists of a team of cross-disciplinary researchers and professionals dedicated to study the ethics and economics of priority setting...

Portrait photo.

Line Bjørge

The main research focus of Professor Line Bjørge's group is ovarian cancer, and the aim is to translate data from comprehensive molecular profiling into clinical meaningful strategies to improve prevention and individualized patient care.

Portrait photo.

Daniela Elena Costea

Professor Daniela Elena Costea and her team in the Experimental Pathology Research Group are focusing on characterizing the interactions between epithelial (stem) cells and their microenvironment in normal conditions and during carcinogenesis.

Portrait photo.

Camilla Krakstad

Professor Camilla Krakstad has her background from research on signal transduction, and during her PhD she studied cAMP signaling in apoptotic cell death in both normal and cancer cells.

Portrait photo.

Elisabeth Wik

Postdoc Elisabeth Wik has been a member of the Tumor Biology Research Group (directed by Akslen) since 2013, in combination with a position as resident at the Department of Pathology, Haukeland University Hospital.